Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Sodium lactate + calcium chloride + magnesium chloride + sodium chloride + dextrose** is a fixed-composition peritoneal dialysis solution used for intraperitoneal dialysis in renal failure. Dextrose creates an osmotic gradient across the peritoneal membrane to promote ultrafiltration and removal of excess fluid, while sodium lactate provides an alkali buffer that supports acid-base balance and the electrolyte salts replace or maintain dialysate sodium, calcium, magnesium, and chloride concentrations. Products with this active-ingredient set are marketed in multiple dextrose concentrations and electrolyte compositions, including Dianeal products from Vantive and Delflex products from Fresenius Medical Care.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on sodium lactate + calcium chloride + magnesium chloride + sodium chloride + dextrose.